| Below
are selected references from those reviewed to prepare the information on
these web pages. These references were chosen to help patients, their families
and health care workers learn more about the thrombophilic conditions.
General References:
1. Bertina, R.M., Molecular risk factors for thrombosis. Thromb
Haemost, 1999. 82(2): p. 601-9.
2. Beutler, E. and W.J. Williams, Williams hematology. 6th ed.
2001, New York: McGraw-Hill Health Professions Division. xxvii, 1941,
106.
3. Brenner, B., et al., Gestational outcome in thrombophilic women
with recurrent pregnancy loss treated by enoxaparin. Thromb Haemost,
2000. 83(5): p. 693-7.
4. Colman, R.W., Hemostasis and thrombosis : basic principles and clinical
practice. 4th ed. 2001, Philadelphia: Lippincott Williams & Wilkins.
xix, 1578 , <32> of plates.
5. Federman, D.G. and R.S. Kirsner, An update on hypercoagulable disorders.
Arch Intern Med, 2001. 161(8): p. 1051-6.
6. Hansson, P.O., J. Sorbo, and H. Eriksson, Recurrent venous thromboembolism
after deep vein thrombosis: incidence and risk factors. Arch Intern
Med, 2000. 160(6): p. 769-74.
7. Hyers, T.M., et al., Antithrombotic therapy for venous thromboembolic
disease. Chest, 2001. 119(1 Suppl): p. 176S-193S.
8. Kearon, C. and J. Hirsh, Management of anticoagulation before and
after elective surgery. N Engl J Med, 1997. 336(21): p. 1506-11.
9. Kearon, C., et al., A comparison of three months of anticoagulation
with extended anticoagulation for a first episode of idiopathic venous
thromboembolism. N Engl J Med, 1999. 340(12): p. 901-7.
10. Kearon, C., M. Crowther, and J. Hirsh, Management of patients with
hereditary hypercoagulable disorders. Annu Rev Med, 2000. 51:
p. 169-85.
11. Kupferminc, M.J., et al., Increased frequency of genetic thrombophilia
in women with complications of pregnancy. N Engl J Med, 1999. 340(1):
p. 9-13.
12. Lensing, A.W., et al., Deep-vein thrombosis. Lancet, 1999.
353(9151): p. 479-85.
13. Rosenberg, R.D. and W.C. Aird, Vascular-bed--specific hemostasis
and hypercoagulable states. N Engl J Med, 1999. 340(20): p.
1555-64.
14. Rosendaal, F.R., Venous thrombosis: a multicausal disease.
Lancet, 1999. 353(9159): p. 1167-73.
15. Seligsohn, U. and A. Lubetsky, Genetic susceptibility to venous
thrombosis. N Engl J Med, 2001. 344(16): p. 1222-31.
Factor V Leiden:
1. Dahlback, B., M. Carlsson, and P.J. Svensson, Familial thrombophilia
due to a previously unrecognized mechanism characterized by poor anticoagulant
response to activated protein C: prediction of a cofactor to activated
protein C. Proc Natl Acad Sci U S A, 1993. 90(3): p. 1004-8.
2. Gerhardt, A., et al., Prothrombin and factor V mutations in women
with a history of thrombosis during pregnancy and the puerperium.
N Engl J Med, 2000. 342(6): p. 374-80.
3. Martinelli, I., et al., The risk of venous thromboembolism in family
members with mutations in the genes of factor V or prothrombin or both.
Br J Haematol, 2000. 111(4): p. 1223-9.
4. Price, D.T. and P.M. Ridker, Factor V Leiden mutation and the risks
for thromboembolic disease: a clinical perspective. Ann Intern Med,
1997. 127(10): p. 895-903.
5. Rees, D.C., M. Cox, and J.B. Clegg, World distribution of factor
V Leiden. Lancet, 1995. 346(8983): p. 1133-4.
6. Ridker, P.M., et al., Age-specific incidence rates of venous thromboembolism
among heterozygous carriers of factor V Leiden mutation. Ann Intern
Med, 1997. 126(7): p. 528-31.
Prothrombin Mutation:
1. De Stefano, V., et al., The risk of recurrent venous thromboembolism
among heterozygous carriers of the G20210A prothrombin gene mutation.
Br J Haematol, 2001. 113(3): p. 630-5.
2. Gerhardt, A., et al., Prothrombin and factor V mutations in women
with a history of thrombosis during pregnancy and the puerperium.
N Engl J Med, 2000. 342(6): p. 374-80.
3. Martinelli, I., et al., The risk of venous thromboembolism in family
members with mutations in the genes of factor V or prothrombin or both.
Br J Haematol, 2000. 111(4): p. 1223-9.
Antiphospholipid Antibody Syndrome:
1. Greaves, M., et al., Guidelines on the investigation and management
of the antiphospholipid syndrome. Br J Haematol, 2000. 109(4):
p. 704-15.
2. Khamashta, M.A., Hughes syndrome : antiphospholipid syndrome.
2000, London ; New York: Springer. xx, 474.
3. Rand, J.H., et al., Pregnancy loss in the antiphospholipid-antibody
syndrome--a possible thrombogenic mechanism. N Engl J Med, 1997. 337(3):
p. 154-60.
|
|
|